Automated reanalysis of genomic data for rare disease diagnostics at scale
Nature Medicine 2026 final publication, 24 June 2026 · Peer-reviewed
What this source contributed
Records in this release that cite this source. A record can cite several sources.
Results
Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.
Claims
Statements this source supports, each with where in the source it was checked.
- Configuration identity: Exomiser v14 default, Talos 2026 comparison: Configuration of Exomiser (Comparison with other tools; Methods)
- Configuration identity: Talos default filtering, 2026 study: Configuration of Talos (Results and Methods; Talos workflow)
- Configuration identity: Talos monthly iterative reanalysis with clinical confirmation: Configuration of Talos (Results and Methods; Talos workflow)
- Configuration identity: Talos strict phenotype-match filtering, 2026 study: Configuration of Talos (Results and Methods; Talos workflow)
- Exomiser v14 default, Talos 2026 comparison: facets.method_types: Facets: method types ["conventional_pipeline"] (Other Exomiser configurations; Yuan et al. 2022 Table 2 classes Exomiser by phenotype comparison)
- Exomiser: facets.method_types: Facets: method types ["conventional_pipeline"] (Other Exomiser configurations; Yuan et al. 2022 Table 2 classes Exomiser by phenotype comparison)
- Published study membership: Exomiser rank-budget recovery in ACG trios: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: ACG full: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: ACG singleton: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: ACG trio: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: RGP full: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: RGP singleton: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos diagnosis recovery and workload: RGP trio: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Published study membership: Talos programme reanalysis yield: Part of Talos 2026 evaluation and reanalysis study (Table1; Results comparison with other tools and iterative reanalysis)
- Relevance of Exomiser rank-budget recovery in ACG trios to "Rank rare-disease variants for review": Assessed by Exomiser rank-budget recovery in ACG trios (uc-clinical-20260930-source-talos: Results Comparison with other tools; Methods; Extended Data Fig1 caption)
- Relevance of Exomiser v14 rank-budget recovery of known diagnoses in ACG trios (Talos 2026) to "Reanalyse unresolved rare-disease cases": Assessed by Exomiser rank-budget recovery in ACG trios (uc-clinical-20260930-source-talos: Results 'Comparison with other tools'; Methods 'Exomiser comparison'; Extended Data Fig. 1 legend)
- Relevance of Talos default versus strict filtering on known diagnoses, ACG full (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: ACG full (uc-clinical-20260930-source-talos-table1: Table 1, ACG full columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, ACG singleton (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: ACG singleton (uc-clinical-20260930-source-talos-table1: Table 1, ACG singleton columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, ACG trio (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: ACG trio (uc-clinical-20260930-source-talos-table1: Table 1, ACG trio columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, RGP full (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: RGP full (uc-clinical-20260930-source-talos-table1: Table 1, RGP full columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, RGP singleton (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: RGP singleton (uc-clinical-20260930-source-talos-table1: Table 1, RGP singleton columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos default versus strict filtering on known diagnoses, RGP trio (Talos 2026 Table 1) to "Reanalyse unresolved rare-disease cases": Assessed by Talos diagnosis recovery and workload: RGP trio (uc-clinical-20260930-source-talos-table1: Table 1, RGP trio columns; uc-clinical-20260930-source-talos: Results; Table 1)
- Relevance of Talos programme reanalysis yield to "Reanalyse unresolved rare-disease cases": Assessed by Talos programme reanalysis yield (uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods)
- Talos default filtering, 2026 study: facets.method_types: Facets: method types ["conventional_pipeline"] (Other Talos configurations; Kaschta 2026)
- Talos monthly iterative reanalysis with clinical confirmation: facets.method_types: Facets: method types ["conventional_pipeline"] (Other Talos configurations; Kaschta 2026)
Models, benchmarks and other records
Methods (2)
Configurations (6)
- Exomiser v14 default, Talos 2026 comparison
- Original clinical/research analysis before Talos programme
- Refreshed conventional reanalysis with equal updated inputs (proposed)
- Talos default filtering, 2026 study
- Talos monthly iterative reanalysis with clinical confirmation
- Talos strict phenotype-match filtering, 2026 study
Benchmarks (1)
Protocols (2)
Datasets (2)
Baselines (3)
Evaluations (2)
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
16 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Artifact retrieved at 2026-09-30T21:24:16Z Source metadata | Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact SHA-256 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec Source metadata | Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact url https://www.nature.com/articles/s41591-026-04477-5 Source metadata | Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Doi 10.1038/s41591-026-04477-5 Source metadata | Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Publication status peer_reviewed Source metadata | Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Retrieved at 2026-09-30T21:43:37Z Source metadata | Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Url https://www.nature.com/articles/s41591-026-04477-5 Source metadata | Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Version Nature Medicine 2026 final publication, 24 June 2026 Source metadata | Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Description Primary source inspected for the scoped extraction; automated review does not establish replication. Source metadata | Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Facets: areas1 values
| Automated reanalysis of genomic data for rare disease diagnostics at scale No field-specific location recorded Version: Nature Medicine 2026 final publication, 24 June 2026 | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
Primary source inspected for the scoped extraction; automated review does not establish replication.
Technical metadata and extraction receipts
Stable ID: uc-clinical-20260930-source-talos
- areas
- dna-genomes
- contexts
- clinical_research
- url
- https://www.nature.com/articles/s41591-026-04477-5
- retrieved at
- 2026-09-30T21:43:37Z
- version
- Nature Medicine 2026 final publication, 24 June 2026
- publication status
- peer_reviewed
- doi
- 10.1038/s41591-026-04477-5
- artifact sha256
- 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec
- artifact url
- https://www.nature.com/articles/s41591-026-04477-5
- artifact retrieved at
- 2026-09-30T21:24:16Z